LCN2 has been applied as a tumor marker in bladder cancer and has been found to be higher in urine of patients’ diagnosed with non-papillary bladder cancer as compared to papillary bladder cancer42. The gene discussed is LCN2; the disease is urinary bladder carcinoma.